Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

Validation of the oesophageal hypervigilance and anxiety scale for chronic oesophageal disease.

Taft TH, Triggs JR, Carlson DA, Guadagnoli L, Tomasino KN, Keefer L, Pandolfino JE.

Aliment Pharmacol Ther. 2018 May;47(9):1270-1277. doi: 10.1111/apt.14605. Epub 2018 Mar 12.

PMID:
29528128
2.

Systematic review: methodological flaws in racial/ethnic reporting for gastroesophageal reflux disease.

Craven MR, Kia L, O'Dwyer LC, Stern E, Taft TH, Keefer L.

Dis Esophagus. 2018 Mar 1;31(3). doi: 10.1093/dote/dox154.

PMID:
29444213
3.

Evaluating the reliability and construct validity of the Eckardt symptom score as a measure of achalasia severity.

Taft TH, Carlson DA, Triggs J, Craft J, Starkey K, Yadlapati R, Gregory D, Pandolfino JE.

Neurogastroenterol Motil. 2018 Jun;30(6):e13287. doi: 10.1111/nmo.13287. Epub 2018 Jan 8.

PMID:
29315993
4.

Psychological Considerations and Interventions in Inflammatory Bowel Disease Patient Care.

Taft TH, Ballou S, Bedell A, Lincenberg D.

Gastroenterol Clin North Am. 2017 Dec;46(4):847-858. doi: 10.1016/j.gtc.2017.08.007. Epub 2017 Oct 3. Review.

PMID:
29173526
5.

Stigma perceptions in patients with eosinophilic gastrointestinal disorders.

Guadagnoli L, Taft TH, Keefer L.

Dis Esophagus. 2017 Jul 1;30(7):1-8. doi: 10.1093/dote/dox014.

PMID:
28475723
6.

Stigmatization toward irritable bowel syndrome and inflammatory bowel disease in an online cohort.

Taft TH, Bedell A, Naftaly J, Keefer L.

Neurogastroenterol Motil. 2017 Feb;29(2). doi: 10.1111/nmo.12921. Epub 2016 Aug 8.

7.

Development and validation of the brief esophageal dysphagia questionnaire.

Taft TH, Riehl M, Sodikoff JB, Kahrilas PJ, Keefer L, Doerfler B, Pandolfino JE.

Neurogastroenterol Motil. 2016 Dec;28(12):1854-1860. doi: 10.1111/nmo.12889. Epub 2016 Jul 5.

8.

Inflammatory Bowel Disease and Skin Cancer: An Assessment of Patient Risk Factors, Knowledge, and Skin Practices.

Kimmel JN, Taft TH, Keefer L.

J Skin Cancer. 2016;2016:4632037. doi: 10.1155/2016/4632037. Epub 2016 Feb 29.

9.

A systematic review of disease-related stigmatization in patients living with inflammatory bowel disease.

Taft TH, Keefer L.

Clin Exp Gastroenterol. 2016 Mar 7;9:49-58. doi: 10.2147/CEG.S83533. eCollection 2016. Review.

10.

Development of the Northwestern Esophageal Quality of Life Scale: A Hybrid Measure for Use Across Esophageal Conditions.

Bedell A, Taft TH, Keefer L, Pandolfino J.

Am J Gastroenterol. 2016 Apr;111(4):493-9. doi: 10.1038/ajg.2016.20. Epub 2016 Feb 16.

11.

Eosinophilic oesophagitis: relationship of quality of life with clinical, endoscopic and histological activity.

Safroneeva E, Coslovsky M, Kuehni CE, Zwahlen M, Haas NA, Panczak R, Taft TH, Hirano I, Dellon ES, Gonsalves N, Leung J, Bussmann C, Woosley JT, Yan P, Romero Y, Furuta GT, Gupta SK, Aceves SS, Chehade M, Straumann A, Schoepfer AM; International EEsAI Study Group.

Aliment Pharmacol Ther. 2015 Oct;42(8):1000-10. doi: 10.1111/apt.13370. Epub 2015 Aug 14.

12.

Development and validation of a symptom-based activity index for adults with eosinophilic esophagitis.

Schoepfer AM, Straumann A, Panczak R, Coslovsky M, Kuehni CE, Maurer E, Haas NA, Romero Y, Hirano I, Alexander JA, Gonsalves N, Furuta GT, Dellon ES, Leung J, Collins MH, Bussmann C, Netzer P, Gupta SK, Aceves SS, Chehade M, Moawad FJ, Enders FT, Yost KJ, Taft TH, Kern E, Zwahlen M, Safroneeva E; International Eosinophilic Esophagitis Activity Index Study Group.

Gastroenterology. 2014 Dec;147(6):1255-66.e21. doi: 10.1053/j.gastro.2014.08.028. Epub 2014 Aug 23.

13.

Moving beyond perceptions: internalized stigma in the irritable bowel syndrome.

Taft TH, Riehl ME, Dowjotas KL, Keefer L.

Neurogastroenterol Motil. 2014 Jul;26(7):1026-35. doi: 10.1111/nmo.12357. Epub 2014 May 16.

PMID:
24832499
14.

Gut-directed hypnotherapy significantly augments clinical remission in quiescent ulcerative colitis.

Keefer L, Taft TH, Kiebles JL, Martinovich Z, Barrett TA, Palsson OS.

Aliment Pharmacol Ther. 2013 Oct;38(7):761-71. doi: 10.1111/apt.12449. Epub 2013 Aug 19.

15.

A preliminary evaluation of internalized stigma and stigma resistance in inflammatory bowel disease.

Taft TH, Ballou S, Keefer L.

J Health Psychol. 2013 Apr;18(4):451-60. doi: 10.1177/1359105312446768. Epub 2012 Jun 11.

PMID:
22689587
16.

Preliminary evaluation of maternal caregiver stress in pediatric eosinophilic gastrointestinal disorders.

Taft TH, Ballou S, Keefer L.

J Pediatr Psychol. 2012 Jun;37(5):523-32. doi: 10.1093/jpepsy/jsr118. Epub 2012 Jan 23.

17.
18.

The adult eosinophilic oesophagitis quality of life questionnaire: a new measure of health-related quality of life.

Taft TH, Kern E, Kwiatek MA, Hirano I, Gonsalves N, Keefer L.

Aliment Pharmacol Ther. 2011 Oct;34(7):790-8. doi: 10.1111/j.1365-2036.2011.04791.x. Epub 2011 Aug 2.

19.

Esophageal symptoms questionnaire for the assessment of dysphagia, globus, and reflux symptoms: initial development and validation.

Kwiatek MA, Kiebles JL, Taft TH, Pandolfino JE, Bové MJ, Kahrilas PJ, Keefer L.

Dis Esophagus. 2011 Nov;24(8):550-9. doi: 10.1111/j.1442-2050.2011.01202.x. Epub 2011 May 19.

PMID:
21595774
20.

Qualitative assessment of patient-reported outcomes in adults with eosinophilic esophagitis.

Taft TH, Kern E, Keefer L, Burstein D, Hirano I.

J Clin Gastroenterol. 2011 Oct;45(9):769-74. doi: 10.1097/MCG.0b013e3182166a5a.

PMID:
21552137

Supplemental Content

Support Center